Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
59.94
+0.91 (1.54%)
Nov 22, 2024, 4:00 PM EST - Market closed
Rhythm Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 3,684 | 2,717 | 1,641 | 502 | 1,314 | 1,009 | |
Market Cap Growth | 137.11% | 65.56% | 227.08% | -61.83% | 30.31% | 9.04% | |
Enterprise Value | 3,640 | 2,419 | 1,295 | 176 | 1,116 | 850 | |
Last Close Price | 59.94 | 45.97 | 29.12 | 9.98 | 29.73 | 22.96 | |
PS Ratio | 32.17 | 35.09 | 69.42 | 159.06 | - | - | |
PB Ratio | 20.97 | 16.00 | 6.21 | 1.77 | 7.89 | 3.59 | |
P/TBV Ratio | 663.52 | 16.69 | 6.40 | 1.79 | 7.89 | 3.59 | |
EV/Sales Ratio | 32.35 | 31.24 | 54.79 | 55.81 | - | - | |
Debt / Equity Ratio | 0.74 | 0.63 | 0.29 | 0.01 | 0.02 | 0.01 | |
Asset Turnover | 0.31 | 0.22 | 0.07 | 0.01 | - | - | |
Inventory Turnover | 1.18 | 1.61 | 1.41 | - | - | - | |
Quick Ratio | 3.25 | 5.27 | 8.53 | 6.81 | 9.60 | 11.98 | |
Current Ratio | 3.49 | 5.58 | 8.90 | 7.10 | 10.10 | 12.38 | |
Return on Equity (ROE) | -147.90% | -85.10% | -66.05% | -30.89% | -59.88% | -53.38% | |
Return on Assets (ROA) | -46.24% | -32.22% | -31.45% | -41.15% | -34.45% | -32.09% | |
Return on Capital (ROIC) | -71.39% | -37.22% | -35.62% | -46.58% | -37.59% | -34.38% | |
Earnings Yield | -7.10% | -6.80% | -11.04% | -13.88% | -10.20% | -13.95% | |
FCF Yield | -3.38% | -5.01% | -10.59% | -29.19% | -9.30% | -12.51% | |
Buyback Yield / Dilution | -6.06% | -10.65% | -5.08% | -12.40% | -21.15% | -17.48% | |
Total Shareholder Return | -6.06% | -10.65% | -5.08% | -12.40% | -21.15% | -17.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.